- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05836493
Very Long-term (>15 Years) Results of Tricuspid Valve Repair.
April 28, 2023 updated by: Michele De Bonis
Interest in Tricuspid valve disease grew exponentially in the last years in response to an increased awareness of the poor outcome of patients with functional Tricuspid Regurgitation (TR).
Earlier reports advocated for a more conservative TR management in patients undergoing left-sided heart valve surgery but more recent guidelines advised for a more aggressive TR management, as accumulating evidence demonstrates its adverse impact on long term morbidity and mortality.
Several papers have been published analyzing the results of surgical tricuspid valve repair but the length of the follow-up is usually limited to 10 to 12 years.
With this study the investigators aim to analyze the very long-term results (>15years) of tricuspid valve repair according to the surgical method employed for valve repair (suture vs ring annuloplasty).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
146
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Milan, Italy, 20132
- Irccs Ospedale San Raffaele
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
- patients operated for non-valvular procedures (e.g.
coronary artery bypass)
Description
Inclusion Criteria:
- cardiac surgery treatment of TR, isolated or in conjunction with other procedures on the left heart
- patients operated on between January 1998 and December 2004
Exclusion Criteria:
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Ring annuloplasty
|
A prosthetic ring is implanted to treat tricuspid regurgitation
|
|
Suture procedure
|
Suture techniques such as Kay or De Vega are used to reduce tricuspid annulus in order to treat tricuspid regurgitation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Mortality
Time Frame: through study completion, a minimum of 15 years
|
through study completion, a minimum of 15 years
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Reintervention
Time Frame: through study completion, a minimum of 15 years
|
through study completion, a minimum of 15 years
|
|
TR recurrence
Time Frame: through study completion, a minimum of 15 years
|
through study completion, a minimum of 15 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 7, 2020
Primary Completion (Actual)
October 23, 2020
Study Completion (Actual)
October 23, 2020
Study Registration Dates
First Submitted
January 27, 2023
First Submitted That Met QC Criteria
April 28, 2023
First Posted (Actual)
May 1, 2023
Study Record Updates
Last Update Posted (Actual)
May 1, 2023
Last Update Submitted That Met QC Criteria
April 28, 2023
Last Verified
April 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- VLT-TVR
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tricuspid Regurgitation
-
Micro Interventional DevicesNot yet recruitingTricuspid Regurgitation | Tricuspid Regurgitation Functional | Severe Tricuspid Valve Regurgitation
-
Tangent Cardiovascular Inc.RecruitingTricuspid Regurgitation | Tricuspid Regurgitation Functional | Tricuspid Regurgitation (TR)Paraguay
-
Icahn School of Medicine at Mount SinaiNational Heart, Lung, and Blood Institute (NHLBI); Canadian Institutes of Health... and other collaboratorsCompletedTricuspid Regurgitation | Mild Tricuspid Regurgitation | Moderate Tricuspid RegurgitationUnited States, Canada, Germany
-
Tau-MEDICAL Co., Ltd.RecruitingTricuspid Regurgitation (TR)Georgia
-
IRCCS Policlinico S. DonatoRecruitingTricuspid Regurgitation CongenitalItaly
-
Heart Center Leipzig - University HospitalRecruitingFunctional Tricuspid RegurgitationGermany
-
University of ZurichRecruitingSevere Tricuspid RegurgitationSwitzerland
-
P+F Products + Features GmbHCompletedSevere Tricuspid RegurgitationLithuania
-
Innoventric LTDInnoventric Inc.RecruitingTricuspid Regurgitation | Tricuspid Regurgitation FunctionalUnited States, Germany
-
Charite University, Berlin, GermanyRecruitingFunctional Tricuspid RegurgitationGermany, Israel
Clinical Trials on Ring annuloplasty
-
Medtronic Bakken Research CenterCompletedMitral Valve InsufficiencyBelgium, Germany, Greece, Norway, Poland
-
Abbott Medical DevicesCompletedMitral Valve RegurgitationNetherlands, Italy, Germany
-
Meshalkin Research Institute of Pathology of CirculationCompletedMitral Regurgitation
-
University Hospital AugsburgUniversitätsklinikum Hamburg-Eppendorf; Heart Center Leipzig - University Hospital and other collaboratorsRecruitingAortic Regurgitation Disease | Bicuspid Aortic Valve (BAV)Germany
-
Medtentia International Ltd OyCompletedMitral Regurgitation | Mitral InsufficiencyFinland
-
Cardiac Implants LLCRecruitingTricuspid Regurgitation FunctionalUnited States
-
Boston Scientific CorporationActive, not recruitingCardiovascular Diseases | Mitral Regurgitation Functional | Mitral Valve DiseaseAustralia, United States
-
Sorin Group USA, Inc.CompletedMitral Valve RegurgitationUnited States, Canada
-
Michele De BonisCompletedFunctional Tricuspid RegurgitationItaly
-
Edwards LifesciencesCompletedMitral Valve InsufficiencyItaly, Belgium